To further investigate how DMAPE (or PepE) manipulates the ROS levels and eliminates the APCs, we first compared the crucial regulators of ROS signaling in primitive CD34+ AML patients specimens versus normal specimens. Here, CD34 is linked to acute myeloid leukemia.